Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy

Whether C5 blocking may improve the outcomes of patients developing chemotherapy-induced thrombotic microangiopathy (TMA) remains elusive. Lung fibrosis is a well-known complication of bleomycin, whereas TMAs are very rare (<20 cases described). Here, we report an exceptional case of a male patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Salhi, Sofiane, Ribes, David, Faguer, Stanislas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Exceptional Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023184/
https://www.ncbi.nlm.nih.gov/pubmed/33841872
http://dx.doi.org/10.1093/ckj/sfaa101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023184/
https://www.ncbi.nlm.nih.gov/pubmed/33841872
http://dx.doi.org/10.1093/ckj/sfaa101

Ejemplares similares